Sign in
CompletedPhase 4

Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty

Key facts

Who runs it
Thammasat University
Where
Thailand1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
82 people enrolled
Started
1 Jul 2021
Ended
1 Mar 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Pregabalin 75mg
  • Pregabalin 150mg
Record updated
16 April 2024

Who can take part

Age
55 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Symptomatic primary knee osteoarthritis undergoing unilateral TKA
  • Aged between 55 and 80 years old
  • Comply with protocol

Who cannot take part

  • Previous surgery on the knee
  • Allergy to any of the medications in this protocol (Pregabalin, Morphine, Paracetamol, Celecoxib, Tramadol, Aspirin)
  • Secondary osteoarthritis of the knee including autoimmune diseases and post-traumatic
  • History of seizure or cerebrovascular diseases
  • GFR < 30ml/min, Severe Liver Function (Child-Pugh C)
  • Contraindicated to spinal anesthesia (SB) or Adductor canal block (ACB)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to compare the efficacy of 75 mg of Pregabalin and 150 mg of Pregabalin in postoperative pain control after TKA.

The 2 groups in the trial

  • 75 mg of PregabalinTreatment being tested

    Participant received 1 tab of 75 mg of Pregabalin and 1 tab of placebo

    Treatment: Pregabalin 75mg

  • 150 mg of PregabalinExisting treatment, for comparison

    Participant received 2 tabs of 75 mg of Pregabalin

    Treatment: Pregabalin 150mg

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty - A Randomized Controlled Trial
Record updated
16 April 2024